Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disorder for which numerous mouse models have been generated. In both AD patients and mouse models, there is increasing evidence that neuronal dysfunction occurs before the accumulation of β-amyloid (Aβ)-containing plaques and neurodegeneration. Characterization of the timing and nature of preplaque dysfunction is important for understanding the progression of this disease and to identify pathways and molecular targets for therapeutic intervention. Hence, we have examined the progression of dysfunction at the morphological, functional, and behavioral levels in the Tg2576 mouse model of AD. Our data show that decreased dendritic spine density, impaired long-term potentiation (LTP), and behavioral deficits occurred months before plaque deposition, which was first detectable at 18 months of age. We detected a decrease in spine density in the outer molecular layer of the dentate gyrus (DG) beginning as early as 4 months of age. Furthermore, by 5 months, there was a decline in LTP in the DG after perforant path stimulation and impairment in contextual fear conditioning. Moreover, an increase in the Aβ42/Aβ40 ratio was first observed at these early ages. However, total amyloid levels did not significantly increase until ≈18 months of age, at which time significant increases in reactive astrocytes and microglia could be observed. Overall, these data show that the perforant path input from the entorhinal cortex to the DG is compromised both structurally and functionally, and this pathology is manifested in memory defects long before significant plaque deposition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The widely used Tg2576 mouse model expresses mutant human APP and displays decreased spine density in the CA1 and dentate gyrus, well before the development of amyloid plaques, further evidence that soluble Aβ oligomers initiate at least some Alzheimer’s disease–related pathology68,95.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [95]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Whereas high-frequency stimulation significantly increased the magnitude of long-term potentiation (LTP) at Schaffer collateral (SC)-CA1 synapses in the hippocampus of wild type (WT) mice, LTP was significantly impaired in 6-to 7-mo-old APP/PS1 mice (17,18).”
From IL-33 ameliorates Alzheimer's disease-like pathology and cognitive decline (2016) · cites this paper as [17]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This is different from the progression in Tg2576, which manifests synaptic damage at an early stage of pathological development (4.5 months) [68,69] with a corresponding decrease in synaptic density markers [70] prior to Aβ plaque development (10 months) [71] and cognitive deficiencies (one year) [72,73].”
From Centella Asiatica Improves Memory and Promotes Antioxidative Signaling in 5XFAD Mice (2019) · cites this paper as [69]
The cited source says what the claim attributes to it.
In the citing paper
“Tg2576 mice began to show impaired LTP and synaptic transmission in dentate gyrus (DG) at 4–5 mo or older (Jacobsen et al., 2006).”
From VPS35 haploinsufficiency increases Alzheimer’s disease neuropathology (2011) · cites this paper as Jacobsen et al., 2006
In the citing paper
“The widely used Tg2576 mouse model expresses mutant human APP and displays decreased spine density in the CA1 and dentate gyrus, well before the development of amyloid plaques, further evidence that soluble Aβ oligomers initiate at least some Alzheimer’s disease–related pathology68,95.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [95]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856
Natural oligomers of the amyloid-β protein specifically disrupt cognitive function
Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., & Ashe, K. H. (2005) · Nature Neuroscience · doi:10.1038/nn1372 · Cited by 1,687
Life and Death of Neurons in the Aging Brain
Morrison, J. H., & Hof, P. R. (1997) · Science · doi:10.1126/science.278.5337.412 · Cited by 1,344
Self-citationDeciphering the Molecular Basis of Memory Failure in Alzheimer's Disease
Walsh, D. M., & Selkoe, D. J. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.010 · Cited by 1,207
Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models
Hsia, A. Y., Masliah, E., McConlogue, L., Yu, G.-Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R. C., Nicoll, R. A., & Mucke, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3228 · Cited by 1,123
Cited by
Items 701–789 of 789
Brelsford, A. R. (2019) · ORCA Online Research @Cardiff (Cardiff University)
Effects of anle138b treatment on amyloid-β neurotoxicity
Thomas, C. (2020) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8233
Koch, B. M. E. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7716
Fornix stimulation, effects on hippocampal oscillations and memory in an AD mice model
Varela, E. V. (2020) · eScholarship@McGill (McGill) · doi:10.82308/18555
Restoring Tip60 HAT/HDAC2 balance in the neurodegenerative brain promotes neural health
Panikker, P., & Elefant, F. (2018) · iDEA - Drexel University Institutional Repository · doi:10.17918/d89m25
Hudkins, R. L., Marino, M. J., & Williams, M. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc242
(2006) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2006.7.nw7
(2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2046
Understanding neurodegeneration with multi-scale images: an integrated neural image analysis system
Fan, J. (2013) · Digital Repository Service (Northeastern University) · doi:10.17760/d20004834
Involvement of Nutrients in the Pathogenesis or Management of Alzheimer’s Disease
Wurtman, R. J. (2011) · touchREVIEWS in Neurology · doi:10.17925/usn.2011.07.02.87
Huffels, C. F. M., van Dijk, R. E., Karst, H., Meye, F. J., Hol, E. M., & Middeldorp, J. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220337
Animal Models of Amyloid/PS-1 Pathology
Takashima, A. (2011) · Royal Society of Chemistry eBooks · doi:10.1039/bk9781849731843-00015
Spatial coding in aging and Alzheimer's disease
Fang, Y. (2022) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/168504
Shirrafiardekani, A., Mirjalili, A., Alashwal, H., & Moustafa, A. A. (2023) · International Conference on Machine Learning and Cybernetics · doi:10.1109/icmlc58545.2023.10327966
Gorskaya, A., & Vasilev, D. S. (2024) · Сенсорные системы · doi:10.31857/s0235009224010017
Gorskaya, A., & Vasilev, D. S. (2024) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-024-01702-x
Caffeine and potential use in Alzheimer’s disease
Büschgens, L., Janitschke, D., Lauer, A. A., Grimm, M. O. W., & Wirths, O. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13868-3.00029-6
Mouse Models of Alzheimer’s Disease
Sanfeliu, C., & Pallàs, M. (2024) · Neuromethods · doi:10.1007/978-1-0716-4232-0_13
Ikezu, T. (2024) · Springer eBooks · doi:10.1007/978-3-031-68237-7_22
Analysis and Control of Alzheimers Disease Models
Lakshmi, N. S. (2025) · Journal of Biomedical Research & Environmental Sciences · doi:10.37871/jbres2124
Andraini, T., Fauré, L. M., Moulédous, L., Gauzin, S., Ghasemi, Z., Lejards, C., Florian, C., Belenguer, P., Miquel, M., & Rampon, C. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107158
Edo, H., Itano, R., & Umezawa, M. (2025) · Environmental Science and Pollution Research · doi:10.1007/s11356-025-37141-5
Impact of A β and Tau on Cognition in Mouse Models of Alzheimer’s Disease
Koike, M. A., Myczek, K., Green, K. N., & LaFerla, F. M. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-422-3_6
Pathological changes leading to neuronal degeneration in Alzheimer's disease
Woodhouse, A. (2008) · UTAS Research Repository · doi:10.25959/23243174
Aβ(1-42) induced metabolic effects in a stem cell derived neuron and astrocyte network.
Tarczyluk, M. A. (2013) · Aston Publications Explorer (Aston University) · doi:10.48780/publications.aston.ac.uk.00020809
Exzitatorische Insuffizienz als Auslöser von Morbus Alzheimer
Sohre, S. (2020) · Gutenberg Open Science · doi:10.25358/openscience-5335
Benítez, D. P., Jiang, S., Wood, J. I., Wang, R., Hall, C. M., Peerboom, C., Wong, N., Stringer, K. M., Vitanova, K. S., Smith, V. C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14992873
Regulator of G protein signaling 6 (RGS6), a critical modulator of neurological function and disease
Spicer, M. M. (2024) · Iowa Research Online (The University of Iowa) · doi:10.25820/etd.006771
Benítez, D. P., Jiang, S., Wood, J. I., Wang, R., Hall, C. M., Peerboom, C., Wong, N., Stringer, K. M., Vitanova, K. S., Smith, V. C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14992879
Benítez, D. P., Jiang, S., Wood, J. I., Wang, R., Hall, C. M., Peerboom, C., Wong, N., Stringer, K. M., Vitanova, K. S., Smith, V. C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14992870
Targeting the M1 muscarinic acetylcholine receptor in neurodegeneration
Hesse, S. (2023) · Enlighten: Theses (The University of Glasgow) · doi:10.5525/gla.thesis.83466
Wander, C. M., Li, Y.-D., Bao, H., Asrican, B., Luo, Y.-J., Sullivan, H. A., Chao, T.-H. H., Zhang, W., Chéry, S. L., Tart, D. S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26582579
Kim, K.-R., Kim, Y., Jeong, H.-J., Kang, J.-S., Lee, S. H., Kim, Y., Lee, S.-H., & Ho, W.-K. (2021) · Figshare · doi:10.6084/m9.figshare.14344403
Benítez, D. P., Jiang, S., Wood, J. I., Wang, R., Hall, C. M., Peerboom, C., Wong, N., Stringer, K. M., Vitanova, K. S., Smith, V. C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14992882
Benítez, D. P., Jiang, S., Wood, J. I., Wang, R., Hall, C. M., Peerboom, C., Wong, N., Stringer, K. M., Vitanova, K. S., Smith, V. C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14992876
Benítez, D. P., Jiang, S., Wood, J. I., Wang, R., Hall, C. M., Peerboom, C., Wong, N., Stringer, K. M., Vitanova, K. S., Smith, V. C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14992867
Additional file 1 of Loss of GDE2 leads to complex behavioral changes including memory impairment
Daudelin, D., Westerhaus, A., Zhang, N., Leyder, E. C., Savonenko, A. V., & Sockanathan, S. (2024) · Figshare · doi:10.6084/m9.figshare.26702176
Additional file 2 of Loss of GDE2 leads to complex behavioral changes including memory impairment
Daudelin, D., Westerhaus, A., Zhang, N., Leyder, E., Savonenko, A. V., & Sockanathan, S. (2024) · Figshare · doi:10.6084/m9.figshare.26702179
Whelan, J. (2021) · Otago University Research Archive (University of Otago)
Parra‐Damas, A., Molecular, U. A. D. B. D. D. B. I. D. B., & de Neurociències, U. A. D. B. I. (2016) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
THE ROLE OF TRANSLATION ELONGATION DEFICITS IN ALZHEIMER’S DISEASE PATHOGENESIS
Beckelman, B. C. (2018) · WakeSpace Scholarship (Wake Forest University)
Jester, H. M. (2020) · WakeSpace Scholarship (Wake Forest University)
Kurbjeweit, L. (.-M. (2013) · URN:NBN Resolver for Germany & Switzerland (German National Library)
Schreurs, A. (2020) · Lirias
Fernandez Fernandez, D. (2015) · Investigo Institutional repository of UVigo (Universidade de Vigo)
Bushra, M. A. (2024) · ThinkTech (Texas Tech University)
Moreno González, I. (2009) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Liu, C., Li, W., Wang, S., Wang, J., Wang, J., Wu, H., Loparo, K. A., & Fietkiewicz, C. (2026) · IEEE Transactions on Neural Networks and Learning Systems · doi:10.1109/tnnls.2026.3666557
Peng, T., Xu, P., Guo, X., Lin, J., Zhang, M., Liu, X., Ye, J., & Lin, X. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261423948
Gonçalves, F. Q., Silva, H. B. L., Tomé, Â. R., Agostinho, P. M., Cunha, R. A., & Lopes, J. P. (2026) · Cells · doi:10.3390/cells15060510
Integrative Spatial Technologies for Mapping Axonal Vulnerability in Alzheimer’s Disease
Leible, D. (2025) · DSpace@MIT (Massachusetts Institute of Technology)
Duncan, W., Fenik, P., Strus, E., Veasey, S. C., & Naidoo, N. N. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.23.713240
Piccand, J. (2012) · theses.fr (ABES) · doi:10.70675/9f80f37azfaacz4e60z8cd8zd178cf6a58ac
Angelo, F. D. (2011) · theses.fr (ABES) · doi:10.70675/73cb4398za753z4fefz9bbaz6dff9a2bb0e1
Boutonnet, M.-C. (2013) · theses.fr (ABES) · doi:10.70675/33d36cb4z9d85z41f4z883dz477d1ad29773
Implication de la phospholipase A2 cytoplamique dans la pathogénèse de la maladie d'Alzheimer
Desbène, C. (2012) · theses.fr (ABES) · doi:10.70675/9db38b81z9958z4e46z87cez29580d7f85e2
Translational potential of the touchscreen-based methodology to assess cognitive abilities in mice
Delotterie, D. F. (2014) · theses.fr (ABES) · doi:10.70675/3cdfec89zb109z45e3za5efz6cf4227ad610
抑肝散の活性成分ガイソシジンメチルエーテルの薬理作用と血液脳関門透過性に関する研究
今村, 幸. (2014) · Institutional Repositories DataBase (IRDB)
Hypothyroïdie et processus neurodégénératifs associés à la maladie d’Alzheimer
Chaalal, A. (2014) · theses.fr (ABES) · doi:10.70675/92c30692zf83fz42c0z8589zdbb1676a28dc
Hippocampal plasticity underlying learning and memory processes in healthy and diseased conditions
Petsophonsakul, P. (2017) · theses.fr (ABES) · doi:10.70675/5fdda64ez871dz42c8za517zf44c3618705e
Dérivés puriques et physiopathologie de la maladie d’Alzheimer
Leuxe, C. (2017) · theses.fr (ABES) · doi:10.70675/0c471421zafedz4712zb5cdz02efab20d706
Ma, F., Akolkar, H., Benosman, R. B., & Herrup, K. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71493
Role of Ryanodine Receptor Clustering in Alzheimer’s Disease
Silva, R. V. (2022) · Otago University Research Archive (University of Otago)
Distinct roles of AMPA receptor subunits as potential therapeutic targets in Alzheimer’s disease
Seo, J., Kim, K., & Park, M. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108394
Gene therapy in Alzheimer’s disease (AD)
Bemanalizadeh, M., Ashrafi, M., Eslami, M., Moein, S., Kazemi, A., & Mansouri, V. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40467-2.00014-2
From Amyloid Exposure to Genetic Causality: Converging hiPSC-Based Models of Alzheimer’s Disease
Colasuonno, F., Valenza, A., Rossin, F., & Moreno, S. (2026) · Cells · doi:10.3390/cells15191793
Tracy, G. (2023) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
Amyloid-β peptide and mitochondrial dysfunction
Yang, A. J. T., & Wilkins, H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45078-5.00022-1
Chakravorty, A., Sharma, A., Sheeba, V., & Manjithaya, R. (2022) · doi:10.3389/fnmol.2022.842772.s003
Hippocampal Dysfunction in the 3xTgAD Mouse Model of Alzheimer's Disease
Davis, K. E. (2012) · Research Explorer (The University of Manchester)
Synapses and Alzheimers’s Disease: Effect of Immunotherapy?
Denham, N. C., Nicoll, J. A. R., & Boche, D. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7061-9_14
Metadata
- Authors
- Jacobsen, J. S., Wu, C.-C., Redwine, J. M., Comery, T. A., Arias, R., Bowlby, M., Martone, R., Morrison, J. H., Pangalos, M. N., Reinhart, P. H., & Bloom, F. E.
- Affiliations
- Wyeth (US)
- Neurome, Inc., La Jolla, CA 92037; and
- Icahn School of Medicine at Mount Sinai (US)
- Scripps Research Institute (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2006-03-20
- Volume
- 103
- Issue
- 13
- Pages
- 5161-5166
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1405622
- OpenAlex
- W2136901555
- Cited by
- 701
- References
- 44
- Citations by year
- 2026: 17 · 2025: 16 · 2024: 26 · 2023: 31 · 2022: 24 · 2021: 32 · 2020: 26 · 2019: 32 · 2018: 35 · 2017: 28 · 2016: 42 · 2015: 26 · 2014: 40 · 2013: 35 · 2012: 46
- FWCI
- 30.71
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, dendritic spine density, long-term potentiation, dentate gyrus, perforant path, contextual fear conditioning, memory impairment, amyloid-beta 42/40 ratio, amyloid plaques, reactive astrocytes, microglia, entorhinal cortex
- MeSH terms
- Aging, Alzheimer Disease, Animals, Behavior, Animal, Brain, Disease Models, Animal, Fear, Memory, Mice, Transgenic, Organ Size, Spine, Synapses, Time Factors, Amyloid beta-Peptides, Synaptophysin, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.